Author:
Tanyanskiy D. A.,Trulioff A. S.,Ageeva E. V.,Nikitin A. A.,Shavva V. S.,Orlov S. V.
Subject
Structural Biology,Biophysics
Reference43 articles.
1. Arita Y., Kihara S., Ouchi N., Takahashi M., Maeda K., Miyagawa J., Hotta K., Shimomura I., Nakamura T., Miyaoka K., Kuriyama H., Nishida M., Yamashita S., Okubo K., Matsubara K., Muraguchi M., Ohmoto Y., Funahashi T., Matsuzawa Y. 1999. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem. Biophys. Res. Commun.
257, 79–83.
2. Tanyanskii D.A., Firova E.M., Shatilina L.V., Denisenko A.D. 2008. Adiponectin: Reduced content in metabolic syndrome nd indenecentconnection with hypertriglyceridemia. Kardiologiya. 12, 20–25.
3. Razgil’dina N.D., Brovin D.L., Pobozheva I.A., Panteleeva A.A., Miroshnikova V.V., Belyaeva O.D., Baranova E.I., Polyakova E.A., Berkovich O.A., Pchelina S.N. 2018. The ADIPOQ gene expression in the subcutaneous and paraabdominal fat tissue of women with different degrees of obesity. Tsitologiya. 60, 531–535.
4. Wang Y., Zheng A., Yan Y., Song F., Kong Q., Qin S., Zhang D. 2014. Association between HMW adiponectin, HMW-total adiponectin ratio and early-onset coronary artery disease in Chinese population. Atherosclerosis. 235, 392–397.
5. Wu Z.J., Cheng Y.J., Gu W.J., Aung L.H. 2014. Adiponectin is associated with increased mortality in patients with already established cardiovascular disease: A systematic review and meta-analysis. Metabolism. 63, 1157–1166.